Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Unknown 4Completed 4

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 5Leukemia 4Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1

Interventions

Cytarabine 35Cyclophosphamide 26Etoposide 18Radiotherapy 16Daunorubicin 16Busulfan 15Peripheral Blood Stem Cell Transplantation 14Methotrexate 14Idarubicin 14Mercaptopurine 12Dexamethasone 12Vincristine 11Thioguanine 9Mitoxantrone 9Doxorubicin 8Asparaginase 8Antilymphocyte Serum 8pegaspargase 7fludarabine phosphate 7Prednisolone 7Polymerase Chain Reaction 7Filgrastim 7Cyclosporine 7Prednisone 6Mycophenolic Acid 5Melphalan 5Leucovorin 5Gene Expression Profiling 5Vindesine 4N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Leukemia × Vindesine × Clear all
NCT00002531 2013-09-17

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Unknown
Other hematologic neoplasm

Leukemia

NCT00002532 2013-08-07

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Unknown
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003728 2011-01-21

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,500 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00764907 2009-07-08

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
4,000 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡